Advertisement
The toll free call in number in the United States is (866) 901-2585. Theinternational call in number is (404) 835-7099.
About the Company
Advertisement
MINRAD International, Inc. is an interventional pain management companywith real-time image guidance and anesthesia and analgesia product lines. Thereal-time image guidance products facilitate minimally invasive surgeryespecially for pain management and have broad applications in orthopedics,neurosurgery, and interventional radiology. These devices enable medicalprofessionals to improve the accuracy of interventional procedures and reduceradiation exposure. MINRAD International also manufactures and marketsgeneric inhalation anesthetics for use in connection with human and veterinarysurgical procedures. The company is developing a drug/drug delivery systemfor conscious sedation, which, similar to nitrous oxide in dental surgery,provides a patient with pain relief without loss of consciousness. Additionalinformation can be found at the company's website, http://www.minrad.com.
The information contained in this news release, other than historicalinformation, consists of forward-looking statements within the meaning of thePrivate Securities Litigation Reform Act of 1995. These statements mayinvolve risks and uncertainties that could cause actual results to differmaterially from those described in such statements. Factors that may causeactual results to differ materially from those expressed or implied by itsforward-looking statements include, but are not limited to, MinradInternational's limited operating history and business development associatedwith being a growth stage company; its dependence on key personnel; its needto attract and retain technical and managerial personnel; its ability toexecute its business strategy; the intense competition it faces; its abilityto protect its intellectual property and proprietary technologies; itsexposure to product liability claims resulting from the use of its products;general economic and capital market conditions; financial conditions of itscustomers and their perception of its financial condition relative to that ofits competitors; as well as those risks described under the heading "RiskFactors" of Minrad International's Form 10-KSB, filed with the Securities andExchange Commission on March 29, 2007. Although Minrad International, Inc.believes that the expectations reflected in such forward-looking statementsare reasonable, it can give no assurance that such expectations will prove tohave been correctContact: Charles R. Trego, Jr., Chief Financial Officer [email protected] (716) 855-1068 www.minrad.com
SOURCE MINRAD International, Inc.
